Form 8-K - Current report:
SEC Accession No. 0001193125-24-273393
Filing Date
2024-12-09
Accepted
2024-12-09 16:01:29
Documents
13
Period of Report
2024-12-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d914555d8k.htm   iXBRL 8-K 47903
  Complete submission text file 0001193125-24-273393.txt   174470

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cogt-20241208.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cogt-20241208_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cogt-20241208_pre.xml EX-101.PRE 11266
15 EXTRACTED XBRL INSTANCE DOCUMENT d914555d8k_htm.xml XML 3625
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38443 | Film No.: 241535035
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)